Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02034721 · ClinicalTrials.gov registry record · NA

Protein and Recovery From Exercise-induced Muscle Damage

A NA study of Inflammation and Muscle Damage, sponsored by Appalachian State University.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT02034721 is a NA study of Inflammation and Muscle Damage that has completed, run by Appalachian State University. The registered enrollment target is 30 participants, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02034721, a NA study of Inflammation and Muscle Damage, has completed, sponsored by Appalachian State University.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

Intense, eccentric resistance exercise causes muscle damage, soreness, inflammation, and a loss of muscle function. Protein-amino acid supplementation before, during, and following damaging resistance exercise may reduce muscle damage and accelerate recovery. This study will determine if supplementation with Herbalife 24 Rebuild Strength (compared to placebo) before, during, and after a 90-minute bout of eccentric exercise attenuates exercise-induced muscle damage, inflammation, and delayed onset of muscle soreness (DOMS), speeds recovery of muscle function, and maintains immune function in NASCAR pit crew athletes (Hendrick Motor Sports).

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Protein supplement

Study Locations (1)

North Carolina

  • ASU-NCRC Human Performance Lab - Kannapolis

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2013-12
Est. Completion 2014-12
Phase NA

Sponsor

Appalachian State University

37 total trials

What the Registry Record Tells You About NCT02034721

The ClinicalTrials.gov registry entry for NCT02034721 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (90% lower). The listed sponsor is Appalachian State University, which has 37 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Inflammation appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT02034721 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT02034721 about?

NCT02034721 is a clinical study titled "Protein and Recovery From Exercise-induced Muscle Damage". Intense, eccentric resistance exercise causes muscle damage, soreness, inflammation, and a loss of muscle function. Protein-amino acid supplementation before, during, and following damaging resistance exercise may reduce muscle damage and accelerate recovery. This study will determine if supplementa...

What is the current status of trial NCT02034721?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2013-12. Estimated completion is 2014-12.

What conditions does trial NCT02034721 study?

This clinical trial studies the following conditions: Inflammation, Muscle Damage.

What interventions are being tested in trial NCT02034721?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Protein supplement (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02034721?

This trial is sponsored by Appalachian State University, which has 37 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02034721 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Inflammation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.